All Pharma News
Cheplapharm places notes in a volume of €750m in challenging market environment

Cheplapharm places notes in a volume of €750m in challenging market environment
PRESS RELEASE
28 Apr 2023
Share Share
Cheplapharm selects Generis’ CARA platform to unify clinical processes

Cheplapharm selects Generis’ CARA platform to unify clinical processes
INDIANPHARMAPOST
20 Jan 2023
Share Share
Astellas Transfers 5 Products in Europe, Russia, CIS & Asia to Cheplapharm

Astellas Transfers 5 Products in Europe, Russia, CIS & Asia to Cheplapharm
PRESS RELEASE
16 Jun 2021
Share Share
Atacand divestment to Cheplapharm in more than 70 countries completed

Atacand divestment to Cheplapharm in more than 70 countries completed
PRESS RELEASE
04 Jan 2021
Share Share
AstraZeneca sells commercial rights to two drugs in $400 million deal

AstraZeneca sells commercial rights to two drugs in $400 million deal
A. Jagadeesh REUTERS
31 Oct 2020
Share Share
LEO Pharma Sells Portfolio of Four Products to Cheplapharm

LEO Pharma Sells Portfolio of Four Products to Cheplapharm
BUSINESSWIRE
04 Sep 2020
Share Share
LEO Pharma Sells Portfolio of Four Products to Cheplapharm

LEO Pharma Sells Portfolio of Four Products to Cheplapharm
BUSINESSWIRE
03 Sep 2020
Share Share
LEO Pharma divests four medicines to Cheplapharm for $357m

LEO Pharma divests four medicines to Cheplapharm for $357m
PHARMACEUTICAL TECHNOLOGY
31 Aug 2020
Share Share
LEO Pharma Sells Portfolio of Four Products to Cheplapharm

LEO Pharma Sells Portfolio of Four Products to Cheplapharm
BUSINESSWIRE
31 Aug 2020
Share Share
AstraZeneca offloads more Seroquel rights, this time to Cheplapharm for $42M

AstraZeneca offloads more Seroquel rights, this time to Cheplapharm for $42M
E. Sagonowsky FIERCE PHARMA
04 Dec 2019
Share Share